Target intelligence / Profile preview

Protein-L-isoaspartate O-methyltransferase domain containing 1 (PCMTD1)

Target
PCMTD1
Molecular classification
Substrate adaptor protein for E3 ubiquitin ligase complexes (specifically Cullin-RING ligase family, SOCS box containing protein), Not an enzyme or receptor under tested conditions
01

Overview

Protein-L-isoaspartate O-methyltransferase domain containing 1 (PCMTD1) is a mammalian protein characterized by the presence of an N-terminal domain similar to l-isoaspartate and S-adenosylmethionine binding motifs, implying structural similarity to PCMT1. Unlike PCMT1, PCMTD1 does not catalyze methyltransferase activity under tested conditions. Instead, it is proposed to function as a substrate adaptor for Cullin-RING E3 ubiquitin ligase complexes by binding to damaged proteins containing l-isoaspartate and facilitating their recognition and possible proteolytic degradation. The protein contains a SOCS box motif responsible for E3 ligase recruitment. PCMTD1 thus forms part of an alternative protein quality control system in mammalian cells, supporting maintenance of protein integrity by targeting damaged proteins for degradation, rather than enzymatic repair.

Other names
PCMTD1Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
02

Mechanism of action

Not yet targeted by drugs; hypothesized mechanism would involve modulation of E3 ubiquitin ligase activity, influencing degradation of damaged proteins

03

Biological functions

Recognizes and binds to l-isoaspartate residues on damaged proteinsBinds S-adenosylmethionine (AdoMet) but does not catalyze methyltransferase activity under tested conditionsAssociates with Cullin-RING proteins and acts as substrate adaptor for ubiquitin ligase-mediated proteolysis of damaged proteinsMay provide an alternative protein quality control pathway in mammalian cells
04

Disease associations

Other (potentially involved in cellular maintenance and protein homeostasis; no direct disease associations currently established for PCMTD1)

Beyond the preview

Go deeper on Protein-L-isoaspartate O-methyltransferase domain containing 1 (PCMTD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-L-isoaspartate O-methyltransferase domain containing 1 (PCMTD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call